HIGHLIGHTS
- who: Mohammed Khurshed et al. from the Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, AZ Amsterdam, The Netherlands have published the research work: Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatinand PARP Inhibitor in IDH1-Mutated Cancer Cells, in the Journal: Cancers 2022, 6228 of /2022/
- what: The authors investigated the additional effects of_(42 u25e6 C for 1 h) in the treatment of IDH1MUT HCT116 colon cancer cells and chondrosarcoma cancer cells in combination with radiation cisplatin and/or PARPi on clonogenic cell survival cell . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.